iRadimed Sees Q3 GAAP EPS $0.49-$0.54 vs $0.49 Est

Benzinga Newsdesk www.benzinga.com Neutral 49.7%

Neg 0% Neu 49.7% Pos 0%

iRadimed (NASDAQ:IRMD) is looking for Q3 GAAP EPS of $0.49-$0.54 vs $0.49 analyst estimate..

Comments

No comments yet. Be the first!